Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1969 1
1971 2
1972 3
1973 4
1974 3
1975 5
1976 6
1977 4
1978 3
1979 7
1980 1
1981 6
1982 8
1983 7
1984 9
1985 4
1986 5
1987 7
1988 4
1989 5
1990 4
1991 11
1992 13
1993 21
1994 23
1995 28
1996 24
1997 38
1998 33
1999 51
2000 54
2001 57
2002 72
2003 81
2004 95
2005 99
2006 94
2007 67
2008 81
2009 82
2010 90
2011 101
2012 90
2013 108
2014 109
2015 97
2016 86
2017 62
2018 67
2019 70
2020 75
2021 90
2022 104
2023 70
2024 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,145 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.
Gess B, Baets J, De Jonghe P, Reilly MM, Pareyson D, Young P. Gess B, et al. Cochrane Database Syst Rev. 2015 Dec 11;2015(12):CD011952. doi: 10.1002/14651858.CD011952. Cochrane Database Syst Rev. 2015. PMID: 26662471 Free PMC article. Review.
MAIN RESULTS: Six RCTs compared the effect of oral ascorbic acid (1 to 4 grams) and placebo treatment in CMT1A. In five trials involving adults with CMT1A, a total of 622 participants received ascorbic acid or placebo. ...Meta-analyses of other seconda …
MAIN RESULTS: Six RCTs compared the effect of oral ascorbic acid (1 to 4 grams) and placebo treatment in CMT1A. In five trials …
Vitamin C for preventing and treating the common cold.
Hemilä H, Chalker E. Hemilä H, et al. Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD000980. doi: 10.1002/14651858.CD000980.pub4. Cochrane Database Syst Rev. 2013. PMID: 23440782 Free PMC article. Review.
BACKGROUND: Vitamin C (ascorbic acid) for preventing and treating the common cold has been a subject of controversy for 70 years. ...
BACKGROUND: Vitamin C (ascorbic acid) for preventing and treating the common cold has been a subject of controversy for 70 yea …
Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis.
Deved V, Poyah P, James MT, Tonelli M, Manns BJ, Walsh M, Hemmelgarn BR; Alberta Kidney Disease Network. Deved V, et al. Am J Kidney Dis. 2009 Dec;54(6):1089-97. doi: 10.1053/j.ajkd.2009.06.040. Epub 2009 Sep 23. Am J Kidney Dis. 2009. PMID: 19783342 Review.
BACKGROUND: Ascorbic acid is believed to improve anemia in patients with end-stage renal disease, but its overall effectiveness is unclear. ...SELECTION CRITERIA FOR STUDIES: Randomized clinical trials of ascorbic acid use in addition to standard anemi …
BACKGROUND: Ascorbic acid is believed to improve anemia in patients with end-stage renal disease, but its overall effectivenes …
Effect of high-dose intravenous ascorbic acid on microcirculation and endothelial glycocalyx during sepsis and septic shock: a double-blind, randomized, placebo-controlled study.
Belousoviene E, Pranskuniene Z, Vaitkaitiene E, Pilvinis V, Pranskunas A. Belousoviene E, et al. BMC Anesthesiol. 2023 Sep 12;23(1):309. doi: 10.1186/s12871-023-02265-z. BMC Anesthesiol. 2023. PMID: 37700249 Free PMC article. Clinical Trial.
Our randomized, double-blind, placebo-controlled trial aimed to investigate whether a high dose of intravenous ascorbic acid (AA) might improve microcirculation and affect glycocalyx in septic patients. ...
Our randomized, double-blind, placebo-controlled trial aimed to investigate whether a high dose of intravenous ascorbic acid ( …
Efficacy of Ascorbic Acid, Thiamine, and Hydrocortisone Combination Therapy: Meta-analysis of Randomized Controlled Trials.
Kato T, Mizuno T, Nakanishi M, Lee JK, Yamada S, Tsuboi N, Takahashi K. Kato T, et al. In Vivo. 2023 May-Jun;37(3):1236-1245. doi: 10.21873/invivo.13200. In Vivo. 2023. PMID: 37103081 Free PMC article.
Although the use of hydrocortisone in combination with ascorbic acid and thiamine (HAT therapy) significantly reduced mortality from sepsis or septic shock in a previous study, it did not improve mortality in subsequent randomized controlled trials (RCTs). ...PATIEN …
Although the use of hydrocortisone in combination with ascorbic acid and thiamine (HAT therapy) significantly reduced mortalit …
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Moskowitz A, Huang DT, Hou PC, Gong J, Doshi PB, Grossestreuer AV, Andersen LW, Ngo L, Sherwin RL, Berg KM, Chase M, Cocchi MN, McCannon JB, Hershey M, Hilewitz A, Korotun M, Becker LB, Otero RM, Uduman J, Sen A, Donnino MW; ACTS Clinical Trial Investigators. Moskowitz A, et al. JAMA. 2020 Aug 18;324(7):642-650. doi: 10.1001/jama.2020.11946. JAMA. 2020. PMID: 32809003 Free PMC article. Clinical Trial.
IMPORTANCE: The combination of ascorbic acid, corticosteroids, and thiamine has been identified as a potential therapy for septic shock. OBJECTIVE: To determine whether the combination of ascorbic acid, corticosteroids, and thiamine attenuates organ in …
IMPORTANCE: The combination of ascorbic acid, corticosteroids, and thiamine has been identified as a potential therapy for sep …
Comparison of 1L Adjuvant Auxiliary Preparations with 2L Solely Polyethylene Glycol plus Ascorbic Acid Regime for Bowel Cleaning: A Meta-analysis of Randomized, Controlled Trials.
Yuan X, Zhang Z, Xie J, Zhang Y, Xu L, Wang W, Xu L. Yuan X, et al. Biomed Res Int. 2021 Feb 18;2021:6638858. doi: 10.1155/2021/6638858. eCollection 2021. Biomed Res Int. 2021. PMID: 33681359 Free PMC article. Review.
This study compared 1L polyethylene glycol plus ascorbic acid with adjuvant drug regimens (1L PEG-AA, lower volume) with 2L polyethylene glycol plus ascorbic acid (2L PEG-A, low volume) to evaluate whether the adjuvants can be used to reduce the standa …
This study compared 1L polyethylene glycol plus ascorbic acid with adjuvant drug regimens (1L PEG-AA, lower volume) with 2L po …
Role of ascorbic acid infusion in critically ill patients with transfusion-related acute lung injury.
Kassem AB, Ahmed I, Omran G, Megahed M, Habib T. Kassem AB, et al. Br J Clin Pharmacol. 2022 May;88(5):2327-2339. doi: 10.1111/bcp.15167. Epub 2022 Jan 7. Br J Clin Pharmacol. 2022. PMID: 34866234 Free article. Clinical Trial.
Recent research raised the potential efficacy of high-dose intravenous ascorbic acid (VC) in critically ill patients. OBJECTIVE: The aim of this trial was to investigate the effect of high-dose intravenous VC as a targeted therapy for TRALI in terms of serum proinfl …
Recent research raised the potential efficacy of high-dose intravenous ascorbic acid (VC) in critically ill patients. OBJECTIV …
Ascorbic acid in bronchial asthma.
Anderson R, Hay I, van Wyk HA, Theron A. Anderson R, et al. S Afr Med J. 1983 Apr 23;63(17):649-52. S Afr Med J. 1983. PMID: 6342165 Clinical Trial.
Sixteen White children with bronchial asthma were divided into two groups; one received standard anti-asthma chemoprophylaxis (SAC) and the other SAC supplemented with 1 g ascorbic acid (Redoxon) given as a single daily dose for a 6-month period. In 10 patients the …
Sixteen White children with bronchial asthma were divided into two groups; one received standard anti-asthma chemoprophylaxis (SAC) and the …
2,145 results